Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Freeze-dried Human Rabies Vaccine (HDC) with Different Schedules
NCT07021703Phase 1Recruiting
- Sponsor
- Ningbo Rongan Biological Pharmaceutical Co., Ltd.
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human diploid cell rabies vaccine in rabies (2 arms), sponsored by Ningbo Rongan Biological Pharmaceutical Co., Ltd. Primary endpoints: Occurrence of AE and AR within 30 minutes after each dose, Occurrence of AE and AR within 7 days after each dose and 3 more. Started May 2025; status: recruiting.
02
Drugs
human diploid cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07021703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07021703.